View in EDS

IL3RA identified as novel biomarker and therapeutic target for ER+ breast cancer through plasma proteome-wide mendelian randomization and TCGA database analysis.

Saved in:
Bibliographic Details
Title: IL3RA identified as novel biomarker and therapeutic target for ER+ breast cancer through plasma proteome-wide mendelian randomization and TCGA database analysis.
Authors: Mei H; Department of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China.; Graduate School, Beijing University of Chinese Medicine, Beijing, China., Zhang Z; School of traditional Chinese medicine, Beijing University of Chinese Medicine, Beijing, China., Jiang N; Graduate School, Beijing University of Chinese Medicine, Beijing, China., Lu W; Department of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China. lu_wenping@sina.com., Chang L; Department of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China., Song Q; Department of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China., Li F; School of traditional Chinese medicine, Beijing University of Chinese Medicine, Beijing, China. lifeng_bucm0610@126.com.
Source: Clinical proteomics [Clin Proteomics] 2026 Mar 05; Vol. 23 (1). Date of Electronic Publication: 2026 Mar 05.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101184586 Publication Model: Electronic Cited Medium: Print ISSN: 1542-6416 (Print) Linking ISSN: 15426416 NLM ISO Abbreviation: Clin Proteomics Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41787256
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: IL3RA identified as novel biomarker and therapeutic target for ER<superscript>+</superscript> breast cancer through plasma proteome-wide mendelian randomization and TCGA database analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mei+H%22">Mei H</searchLink>; Department of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China.; Graduate School, Beijing University of Chinese Medicine, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Z%22">Zhang Z</searchLink>; School of traditional Chinese medicine, Beijing University of Chinese Medicine, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Jiang+N%22">Jiang N</searchLink>; Graduate School, Beijing University of Chinese Medicine, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Lu+W%22">Lu W</searchLink>; Department of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China. lu_wenping@sina.com.<br /><searchLink fieldCode="AU" term="%22Chang+L%22">Chang L</searchLink>; Department of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Song+Q%22">Song Q</searchLink>; Department of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Li+F%22">Li F</searchLink>; School of traditional Chinese medicine, Beijing University of Chinese Medicine, Beijing, China. lifeng_bucm0610@126.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101184586%22">Clinical proteomics</searchLink> [Clin Proteomics] 2026 Mar 05; Vol. 23 (1). <i>Date of Electronic Publication: </i>2026 Mar 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101184586 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1542-6416 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215426416%22">15426416 </searchLink><i>NLM ISO Abbreviation: </i>Clin Proteomics <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41787256
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12014-026-09594-4
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: IL3RA identified as novel biomarker and therapeutic target for ER+ breast cancer through plasma proteome-wide mendelian randomization and TCGA database analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mei H
      – PersonEntity:
          Name:
            NameFull: Zhang Z
      – PersonEntity:
          Name:
            NameFull: Jiang N
      – PersonEntity:
          Name:
            NameFull: Lu W
      – PersonEntity:
          Name:
            NameFull: Chang L
      – PersonEntity:
          Name:
            NameFull: Song Q
      – PersonEntity:
          Name:
            NameFull: Li F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 03
              Text: 2026 Mar 05
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1542-6416
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical proteomics
              Type: main
ResultId 1